title: Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer".
authors.forename: Antonietta
authors.initials: A
authors.lastname: Santoro
authors.forename: Patrizia
authors.initials: P
authors.lastname: Gazzerro
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Malfitano
authors.forename: Simona
authors.initials: S
authors.lastname: Pisanti
authors.forename: Chiara
authors.initials: C
authors.lastname: Laezza
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bifulco
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002277:Carcinoma / Q000139:chemically induced / Q000517:prevention & control*; D002470:Cell Survival / Q000187:drug effects; D015179:Colorectal Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D051379:Mice; D009765:Obesity / Q000188:drug therapy*; D010880:Piperidines / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors*; D000077285:Rimonabant; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D019440:Anti-Obesity Agents; D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; C103505:AM 251; D000077285:Rimonabant